Research Associate, Molecular Biology
- Employer
- Molecular Templates, Inc.
- Location
- Austin, TX, USA
- Start date
- Aug 28, 2020
View more
- Discipline
- Science/R&D, Research, Molecular Biology
- Required Education
- Associate Degree
- Position Type
- Full time
Job Details
Molecular Templates (MTEM) is a clinical stage biopharmaceutical company developing targeted therapeutics using its innovative proprietary Engineered Toxin Body (ETB) platform. MTEM's first immunotoxin, MT-3724, is in clinical development for non-Hodgkin's lymphoma. Pipeline products for additional targets and indications are being advanced toward clinical development. For more information, please visit MTEM's website at:
www.moleculartemplates.com.
Position Overview:
The Research Associate (RA) is an integral member of the research and development (R&D) team and will be involved in ETB protein production and analysis. This is a laboratory-based position in a team setting. The RA will be responsible for conducting protein production, analysis, and characterization tasks based on established protocols with all work being documented. Responsibilities may change in line with prioritization at the discretion of the management team.
Job Responsibilities will include:
- Performs research and/or development in collaboration with others for projects.
- Makes detailed observations, analyzes data, and interprets results.
- Maintains a high level of professional expertise through familiarity with internal training and scientific literature, as appropriate for the level of work assigned.
- Presents data and methods in R&D meetings, as needed and assigned.
- Accurately documents all tasks in a timely manner.
- Assists in the design and execution of new experiments or test protocols as needed under the direction of management.
- Performs general lab maintenance including equipment upkeep, lab cleanliness and organization and solution/reagent preparation
- Produces and purifies ETB proteins in an E.coli- based expression system according to established protocols.
- Conducts analytical protein assays according to established protocols.
- Other duties and responsibilities may be assigned by supervisor, as needed.
Qualifications:
- A bachelor's degree in a life science, chemistry, pharmaceutical science or related field is strongly preferred.
- Previous lab-based experience (academic or industry) is required. Seeking 1-3 years of experience in a lab setting.
- Ability to work on problems and projects of limited scope (defined by management).
- Demonstrated ability to safely follow detailed directions and protocols in a laboratory environment
- Relevant experience in a laboratory setting involving molecular biology and recombinant protein expression from a prokaryotic (E. coli) system is desirable
- Experience conducting analytical protein assays (i.e. SDS-PAGE)
- Ability to work in a fast-paced, team environment.
- Ability to build stable working relationships with team members.
- Strong time-management skills.
- Strong written and verbal communication skills.
- Computer skills with knowledge of spreadsheet and word processing software.
Reporting Structure:
This position reports to R&D management. This can vary in level depending on the specific assignments.
Molecular Templates, Inc. is an Equal Opportunity Employer and offers competitive salaries and benefits.
Molecular Templates Inc https://mtem.isolvedhire.com
Company
Molecular Templates, Inc. (MTEM) is a clinical stage biopharmaceutical company focused on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform with unique mechanisms of actions which are highly differentiated from antibody drug conjugates (ADCs). MTEM is developing MT-6402, which is in a Phase I clinical trial for PD-1/PD-L1 antibody relapsed/refractory patients; MT-5111, which is in a Phase I clinical trial for the treatment of HER2-positive cancers; and MT-0169, which is in a Phase I clinical trial to treat relapsed/refractory myeloma. Additional preclinical compounds derived from our ETB platform technology are being advanced toward clinical development. Additional information about MTEM can be obtained at www.mtem.com.
OWNERSHIP: Public
STOCK SYMBOL: MTEM
STOCK EXCHANGE: NASDAQ
- Website
- http://mtem.com/
- Phone
- 512-869-1555
- Location
-
9301 Amberglen Blvd, Ste 100
Austin
TX
78729
US
Get job alerts
Create a job alert and receive personalized job recommendations straight to your inbox.
Create alert